IL22712A - Composition for reducing the cholesterol content in the human body containing pentaerythrityl nicotinate - Google Patents
Composition for reducing the cholesterol content in the human body containing pentaerythrityl nicotinateInfo
- Publication number
- IL22712A IL22712A IL2271265A IL2271265A IL22712A IL 22712 A IL22712 A IL 22712A IL 2271265 A IL2271265 A IL 2271265A IL 2271265 A IL2271265 A IL 2271265A IL 22712 A IL22712 A IL 22712A
- Authority
- IL
- Israel
- Prior art keywords
- nicotinate
- pharmaceutical composition
- human body
- nicotinic acid
- cholesterol content
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1226564 | 1964-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL22712A true IL22712A (en) | 1969-02-27 |
Family
ID=20295449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2271265A IL22712A (en) | 1964-10-13 | 1965-01-01 | Composition for reducing the cholesterol content in the human body containing pentaerythrityl nicotinate |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB1022880A (en(2012)) |
| IL (1) | IL22712A (en(2012)) |
| NL (1) | NL6413246A (en(2012)) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3479364A (en) * | 1967-07-17 | 1969-11-18 | Searle & Co | Pyridinecarboxylic acid esters of benzenehexol |
-
1964
- 1964-11-13 NL NL6413246A patent/NL6413246A/xx unknown
- 1964-11-18 GB GB4701264A patent/GB1022880A/en not_active Expired
-
1965
- 1965-01-01 IL IL2271265A patent/IL22712A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1022880A (en) | 1966-03-16 |
| NL6413246A (en(2012)) | 1966-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4556678A (en) | Sustained release propranolol tablet | |
| US4393071A (en) | Method of treating gastric, mammary, lung and uterus tumors | |
| US5792476A (en) | Sustained release glucocorticoid pharmaceutical composition | |
| EP0531155B1 (en) | Cerebral-Activating Compositions | |
| CA1177408A (en) | Use of pyridoxine alfa-ketoglutarate in the prophylaxis of hyperlacticacidaemia | |
| EP0514328B1 (de) | Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane | |
| JPH08283154A (ja) | 脂質代謝改善剤 | |
| DE3162614D1 (en) | Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same | |
| DE69612540T2 (de) | Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von Krankheiten in Zusammenhang mit aktivem Sauestoff und freien Radikalen | |
| US3830824A (en) | Physiological organic acid silver allantoinates | |
| DE3638124A1 (de) | Neue pharmazeutische verwendung von ebselen | |
| EP0451869B1 (en) | Use of steroid derivatives in the treatment of endometriosis | |
| IL22712A (en) | Composition for reducing the cholesterol content in the human body containing pentaerythrityl nicotinate | |
| EP0471388B1 (de) | Mittel zur Behandlung der Herzinsuffizienz | |
| CN113456639A (zh) | 一种抗心律失常的药物组合物及制备方法 | |
| US3362879A (en) | Tyrosine tranquilizing compositions and methods of treatment | |
| JPS6028811B2 (ja) | 新規アルミニウム化合物、その製法及びこの化合物を含有する燐酸塩結石症治療剤 | |
| Thayer et al. | Vitamin K potencies of synthetic compounds | |
| DE2743704C2 (de) | L- oder DL-Phenylglycine enthaltende Arzneimittel | |
| Walter | Clinical impressions on treatment of obsessional states with intravenous clomipramine (Anafranil) | |
| JP2773895B2 (ja) | ダナゾール組成物 | |
| JP3306459B2 (ja) | アミロイド症予防及び治療剤 | |
| US3934009A (en) | Agents for lowering the lipid level in plasma | |
| US3496267A (en) | Pharmaceutical compositions containing lyophilized cardiac mitochondria | |
| SU1613956A1 (ru) | Средство дл модул ции функциональной активности естественных киллеров IN VIтRо |